Carolina Batista | Pharmaceutical Science | Women Researcher Award

Posted on by ScienceFather

Dr. Carolina Batista | Pharmaceutical Science | Women Researcher Award

Biomedical from Federal University of Rio de Janeiro, Brazil

Dr. Carolina Batista is a distinguished global health physician with over two decades of experience in humanitarian and public health initiatives. Currently serving as the Head of Global Health Affairs at Baraka Impact Finance, she leverages her medical expertise and strategic insight to foster innovative health solutions for underserved populations. Her career commenced in Brazil, where she provided medical care to indigenous communities in the Amazon. In 2007, she joined Médecins Sans Frontières (MSF), undertaking assignments in Somalia, Africa, and Latin America, focusing on neglected tropical diseases (NTDs) and emerging infectious diseases. As Director of MSF’s Brazilian Medical Unit, she led international campaigns, notably for Chagas disease. Subsequently, at the Drugs for Neglected Diseases initiative (DNDi), she spearheaded access frameworks for NTDs across Latin America, influencing public policies and fostering partnerships. Dr. Batista holds a medical degree from Brazil and a master’s in International Public Health from institutions including the Swiss Tropical and Public Health Institute. Her contributions extend to roles on the International Board of MSF, The Lancet COVID-19 Commission, and as a strategic advisor for ISGlobal, reflecting her commitment to health equity and innovation in global health.

Professional Profile

Education

Dr. Carolina Batista’s educational journey is marked by a blend of clinical training and global public health expertise. She earned her medical degree in Brazil, grounding her in clinical practice and primary healthcare delivery. Pursuing a broader impact, she obtained a master’s degree in International Public Health through a collaborative program involving the Swiss Tropical and Public Health Institute, the Institute of Tropical Medicine in Antwerp, and the Royal Tropical Institute in Amsterdam. This multidisciplinary education equipped her with a comprehensive understanding of global health challenges, particularly in infectious and neglected diseases. Further enhancing her capabilities, Dr. Batista pursued advanced studies in management, health and human rights, and policy and advocacy from renowned institutions. This diverse educational background has been instrumental in her ability to design and implement effective health interventions and policies across various international contexts.

Professional Experience

Dr. Carolina Batista’s professional trajectory encompasses significant roles in global health organizations. Her career began in Brazil, providing medical care to indigenous communities in the Amazon. In 2007, she joined Médecins Sans Frontières (MSF), undertaking assignments in Somalia and later serving as Director of the Brazilian Medical Unit, focusing on neglected tropical diseases (NTDs) and emerging infectious diseases. She led international campaigns, notably for Chagas disease, and coordinated MSF’s medical response to COVID-19 in the Navajo Nation, USA. At the Drugs for Neglected Diseases initiative (DNDi), she served as Head of Access and Medical Affairs, developing access frameworks for NTDs across Latin America. Currently, as Head of Global Health Affairs at Baraka Impact Finance, she supports social entrepreneurs in developing innovative health solutions. Dr. Batista also holds positions on the International Board of MSF and serves as a strategic advisor for ISGlobal

Research Interests

Dr. Carolina Batista’s research interests are deeply rooted in global health equity, focusing on neglected tropical diseases (NTDs), health systems in low- and middle-income countries, and access to healthcare for vulnerable populations. She is particularly interested in the development and implementation of innovative financing mechanisms to achieve the Sustainable Development Goals (SDGs), the role of private capital in bridging healthcare access gaps, and the integration of ethical artificial intelligence in health communication. Her work also explores the intersection of migration and health, pandemic preparedness, and the gender gap in healthcare access. Dr. Batista’s research aims to inform policies and practices that enhance healthcare delivery and accessibility for marginalized communities worldwide.

Research Skills

Dr. Carolina Batista possesses a robust set of research skills that encompass both qualitative and quantitative methodologies. Her expertise includes treatment protocols, health systems analysis, diagnostics, and primary care, particularly concerning parasitic and neglected diseases. She is adept at designing and implementing operational research projects, developing access frameworks, and conducting policy analysis. Her skills extend to evaluating health programs, engaging with stakeholders, and advocating for policy changes. Dr. Batista’s proficiency in these areas enables her to contribute effectively to research initiatives aimed at improving health outcomes in underserved populations.

Awards and Honors

Dr. Carolina Batista’s contributions to global health have been recognized through various appointments and memberships. She serves on the International Board of Médecins Sans Frontières (MSF) and is a strategic advisor for the Barcelona Institute for Global Health (ISGlobal). Her role in leading MSF’s medical response to COVID-19 in the Navajo Nation and her involvement in The Lancet COVID-19 Commission underscore her commitment to addressing health crises. Additionally, she chairs the DNDi Latin America board and serves on the boards of The Lancet Migration Latin America, Movement Health Foundation, and Health in Harmony. These positions reflect her leadership and dedication to advancing health equity and innovation.

Conclusion

Dr. Carolina Batista exemplifies a career dedicated to advancing global health equity through clinical practice, research, and policy development. Her extensive experience with organizations like MSF and DNDi, coupled with her strategic role at Baraka Impact Finance, highlights her commitment to improving healthcare access for marginalized populations. Her educational background and research interests inform her holistic approach to health challenges, integrating innovative solutions with traditional practices. Dr. Batista’s leadership roles and board memberships further demonstrate her influence in shaping global health policies and initiatives. Her work continues to inspire and drive progress towards equitable healthcare worldwide.

Publications Top Notes

1. Exposed Subsoil Under Recovery for 30 Years: Influence of Management Strategies on Soil Physical Attributes and Organic Matter

  • Authors: Laura Silva Nantes, Carolina dos Santos Batista Bonini, Melissa Alexandre Santos, Lucas da Silva Alves, Josiane Lourencetti, Alfredo Bonini Neto, José Augusto Liberato de Souza, Gabriel Augusto da Silva Lunardelli, Mariana Bonini Silva, Dayara Vivian Alvares, et al.

  • Year: 2025

2. Accumulated Carbon Fractions in Tropical Sandy Soils and Their Effects on Fertility and Grain Yield in an Integrated Crop–Livestock System

  • Authors: Deyvison de Asevedo Soares, Bianca Midori Souza Sekiya, Viviane Cristina Modesto, Allan Hisashi Nakao, Leandro Alves Freitas, Isabela Malaquias Dalto de Souza, J.H.S. Luz, Fernando Shintate Galindo, Gelci Carlos Lupatini, Gustavo Pavan Mateus, et al.

  • Year: 2023

3. Evolution of Soil Chemical Fertility in an Area under Recovery for 30 Years with Anthropic Intervention

  • Authors: Josiane Lourencetti, Carolina dos Santos Batista Bonini, Marcelo Andreotti, Marlene Cristina Alves, Alfredo Bonini Neto, Melissa Alexandre Santos, Vitor Correa de Mattos Barretto, Roberth Wicleff Rodrigues de Figueredo

  • Year: 2023

4. Long-Term Integrated Systems of Green Manure and Pasture Significantly Recover the Macrofauna of Degraded Soil in the Brazilian Savannah

  • Authors: Carolina dos Santos Batista Bonini, Thais Monique de Souza Maciel, Bruno Rafael de Almeida Moreira, José Guilherme Marques Chitero, Rodney Lúcio Pinheiro Henrique, Marlene Cristina Alves

  • Year: 2023

5. Long-Term Integrated Crop–Livestock–Forestry Systems Recover the Structural Quality of Ultisol Soil

  • Authors: Aline Matos, Carolina dos Santos Batista Bonini, Bruno Rafael de Almeida Moreira, Marcelo Andreotti, Reges Heinrichs, Diogo Tiago da Silva, José Augusto Liberato de Souza, Melissa Alexandre Santos, Cristiana Andrighetto, Gustavo Mateus Pavan, et al.

  • Year: 2022

6. Azospirillum Inoculation of ‘Marandu’ Palisade Grass Seeds: Effects on Forage Production and Nutritional Status

  • Authors: Reges Heinrichs, G.C. Meirelles, L.F. de Melo Santos, M.V. da Silva Lira, A. de Marcos Lapaz, M.A. Nogueira, C. dos Santos Batista Bonini, Filho, A. Moreira

  • Year: 2020

7. Can Palisade and Guinea Grass Sowing Time in Intercropping Systems Affect Soybean Yield and Soil Chemical Properties?

  • Authors: N.R. Costa, Marcelo Andreotti, C.A.C. Crusciol, C.M. Pariz, J.W. Bossolani, A.M.D. Castilhos, C.A.C.D. Nascimento, C.G.D.R. Lima, C. dos Santos Batista Bonini, E.E. Kuramae

  • Year: 2020

8. Effect of Sulfur Sources on Megathyrsus Maximus ‘Mombaça’ Grass Cultivated in a Typic Ultisol

  • Authors: L.F. de Melo Santos, A. de Marcos Lapaz, F.V. Ribeiro, I.V. Ribeiro, G.C. Meirelles, M.V. da Silva Lira, C.V. Soares Filho, C. dos Santos Batista Bonini, A.R. dos Reis, A. Moreira, et al.

  • Year: 2020

9. Soil Compaction in Crop-Livestock-Forest Integration Systems of Five Years of Implantation and Use

  • Authors: J.F.D. Souza, C. dos Santos Batista Bonini, G.P. Mateus, C.T. de Souza, R.L.S. Perusso, F.G. Pedro, G.L. Oliverio

  • Year: 2020

10. Spray Nozzles and Droplet Size Effects on Soybean Canopy Deposits and Stink Bugs Control in West Region of São Paulo State – Brazil

  • Authors: M.A.G.L. Farias, C.G. Raetano, R.G. Chechetto, P.J. Ferreira-Filho, J.C. Guerreiro, C.S.B. Bonini, A.C. Firmino, R.C. Lima, E.P. Prado

  • Year: 2020

​






	


	

	






	
	

		


Hafiz Hussain | Pharmaceutical Science | Best Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Assist. Prof. Dr. Hafiz Hussain | Pharmaceutical Science | Best Researcher Award


Assistant Professor at Cholistan University of Veterinary and Animal Sciences Bahawalpur, Pakistan


Dr. Hafiz Iftikhar Hussain is an esteemed Assistant Professor in the Department of Pathology at Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur, Pakistan. With a strong background in veterinary pathology, he has made significant contributions to research and academia. His expertise lies in bacterial and viral disease pathology in poultry and livestock, with a focus on antibiotic resistance and molecular diagnostics. Dr. Hussain has extensive experience in research methodologies, including whole-genome sequencing, transcriptomic profiling, and biofilm detection. As a dedicated academician, he also serves as Coordinator for undergraduate programs and Additional Director of Student Affairs at CUVAS. He is an active member of several professional associations, including the Pakistan Veterinary Medical Council and the Pakistan Biological Safety Association. His commitment to scientific excellence is evident through his numerous publications, conference presentations, and roles as a reviewer for prestigious journals. Dr. Hussain’s passion for advancing veterinary sciences, particularly in pathology and disease control, underscores his professional journey. His remarkable achievements, including scholarships, best paper awards, and active participation in national and international conferences, reflect his dedication to research, education, and the betterment of animal health sciences in Pakistan and beyond.


Professional Profile



Education


Dr. Hafiz Iftikhar Hussain has an impressive academic background in veterinary sciences and pathology. He earned his Doctor of Philosophy (PhD) in Basic Veterinary Medicine, specializing in Pathobiology, from Huazhong Agricultural University, China, in 2017, with an outstanding score of 81.75%. Prior to his PhD, he completed a Master of Philosophy (M.Phil) in Pathology from the University of Agriculture, Faisalabad, in 2012, focusing on histopathology and toxicology with a commendable CGPA of 3.81/4.00. His foundational education includes a Doctor of Veterinary Medicine (DVM) degree from the University of Agriculture, Faisalabad, completed in 2010, with a CGPA of 3.26/4.00. Dr. Hussain began his academic journey with a Higher Secondary School Certification (F.Sc. Pre-Medical) from the Federal Board of Intermediate and Secondary Education, Islamabad, securing 74% marks in 2005. His early education was completed with a Secondary School Certification in Science from the Board of Intermediate and Secondary Education, Sargodha, where he achieved an excellent 85.77% in 2003. His strong educational foundation has equipped him with advanced knowledge in veterinary pathology, toxicology, and molecular diagnostics, laying the groundwork for his research and academic pursuits in veterinary sciences.


Professional Experience


Dr. Hafiz Iftikhar Hussain has amassed extensive professional experience in veterinary pathology and academia. His career began as a self-employed veterinary doctor at Al-Shifa Veterinary Clinic and Lab in Farooka, Sargodha, from August 2012 to August 2013. He then transitioned to academia as an Assistant Professor in the Department of Veterinary Pathology at PMAS-Arid Agriculture University, Rawalpindi, where he served from July to December 2018. Since December 2018, Dr. Hussain has been an Assistant Professor in the Department of Pathology at Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur. Alongside his teaching responsibilities, he plays a crucial administrative role as the Coordinator for BS Doctor of Veterinary Medicine (DVM) and BS Medical Laboratory Technology programs. Additionally, he serves as the Additional Director of Student Affairs at CUVAS, demonstrating his leadership and commitment to academic excellence. Dr. Hussain is an active member of professional organizations such as the Pakistan Veterinary Medical Council and the Pakistan Biological Safety Association. His experience spans both clinical practice and academia, making him a distinguished figure in veterinary pathology and a mentor for aspiring veterinarians in Pakistan.


Research Interests


Dr. Hafiz Iftikhar Hussain’s research interests lie at the intersection of veterinary pathology, microbiology, and molecular diagnostics. His primary focus is on antibiotic resistance mechanisms, bacterial pathogenesis, and molecular characterization of multidrug-resistant pathogens, particularly Escherichia coli in poultry. He has conducted extensive research on extended-spectrum beta-lactamase (ESBL) detection and whole-genome sequencing to understand resistance genes in bacterial populations. His studies also explore the pathogenesis of viral and bacterial diseases in poultry and livestock, with an emphasis on biofilm formation and detection. Additionally, Dr. Hussain has a keen interest in transcriptomic profiling, protein extraction, and the development of animal models to study disease mechanisms. His research contributes to the global fight against antimicrobial resistance, aiming to develop strategies for better disease control and prevention in veterinary medicine. As an advocate for One Health, he also investigates zoonotic disease transmission and its implications for public health. His work has been widely recognized, earning him numerous publications in high-impact journals and invitations to present at international conferences. Through his research, Dr. Hussain strives to enhance disease diagnosis, treatment, and control strategies to improve animal and human health.


Research Skills


Dr. Hafiz Iftikhar Hussain possesses a comprehensive skill set in veterinary pathology and molecular diagnostics. His expertise includes antibiotic resistance determination, extended-spectrum beta-lactamase (ESBL) detection, and whole-genome re-sequencing. He is proficient in high-performance liquid chromatography (HPLC), polymerase chain reaction (PCR), and DNA, RNA, and protein extraction techniques. His research capabilities extend to RNA sequencing, biofilm formation studies, enzyme-linked immunosorbent assay (ELISA), and spectrophotometry. Dr. Hussain is also experienced in developing cell lines and utilizing animal modeling for disease studies. In addition to his laboratory skills, he is well-versed in various bioinformatics tools, enabling him to analyze complex genomic data efficiently. His proficiency in Microsoft Office, Adobe Photoshop for scientific presentations, and statistical analysis software further supports his research endeavors. Dr. Hussain’s technical expertise has been instrumental in advancing his research on antimicrobial resistance, bacterial pathogenesis, and disease diagnostics. His ability to integrate traditional pathology techniques with modern molecular approaches makes him a valuable contributor to veterinary sciences. With a strong commitment to continuous learning and innovation, he remains at the forefront of veterinary research, working to enhance disease control strategies in animal health.


Awards and Honors


Dr. Hafiz Iftikhar Hussain has received numerous accolades for his academic and research contributions. He was awarded a scholarship from the Chinese Scholarship Council for his PhD studies at Huazhong Agricultural University. Throughout his education, he was a consistent scholarship holder from grade six to his PhD. In recognition of his outstanding research, he won the ‘Best Student Paper Award’ at the First Annual Academic Symposium for International Students in 2018 at Huazhong Agricultural University. His academic achievements include earning the esteemed Sahadat-e-Hifz-ul-Quran certification from Wafaq-ul-Madaris, Islamabad. As a recognized expert, Dr. Hussain is a certified reviewer for the ‘Antimicrobial Resistance & Infection Control’ journal and serves as a reviewer for high-impact journals, including Frontiers in Veterinary Science and PLOS ONE. His dedication to veterinary sciences and research has positioned him as a leader in his field, making significant contributions to veterinary pathology and microbiology. These honors reflect his unwavering commitment to excellence, research innovation, and the advancement of animal health sciences at both national and international levels.


Conclusion


Dr. Hafiz Iftikhar Hussain stands as a distinguished figure in veterinary pathology, academia, and research. His extensive expertise in bacterial and viral disease pathology, antimicrobial resistance, and molecular diagnostics has significantly contributed to veterinary sciences. With a strong academic background, he has successfully combined clinical practice, teaching, and research to mentor future veterinarians. His role as an Assistant Professor, program coordinator, and student affairs director at CUVAS demonstrates his leadership and dedication to education. Through his research, he has made remarkable advancements in understanding antibiotic resistance and bacterial pathogenesis, earning prestigious awards and international recognition. His technical skills in genomics, pathology, and bioinformatics further enhance his contributions to disease control and prevention. As an active member of professional organizations and a reviewer for high-impact journals, Dr. Hussain continues to influence the field of veterinary medicine. His commitment to scientific excellence and student mentorship underscores his vision for a healthier future in veterinary and public health. His work remains instrumental in shaping the next generation of veterinary professionals and improving animal health through innovative research and education.


Publications Top Notes


    

  1. 

    “Optimization and production of highly stable amylase isolated from Citrobacter portucalensis using low-cost agro-industrial wastes as substrates: Prospective therapeutics”
    

      

    • Authors: Ume E. Salma Liaqat, Shumaila Naz, Hafiz Iftikhar Hussain
      • 

    • Year: 2024
      • 

    • Journal: Kuwait Journal of Science
      • 

    

    2. 

  2. 

    “Phytochemical Screening, Anti-Inflammatory, and Antidiabetic Activities of Different Extracts from Caralluma edulis Plant”
    

      

    • Authors: Maria Khan, Zahid Manzoor, Muhammad Q. Rafiq, Katarzyna Kotwica-Mojzych, Mariusz Mojzych
      • 

    • Year: 2022
      • 

    • Journal: Molecules
      • 

    • Citations: 9
      • 

    

    3. 



 



	


	

	






	
	

		


Rashna Mirza | Pharmaceutical Science | Best Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Ms. Rashna Mirza | Pharmaceutical Science | Best Researcher Award


PhD scholar of Quaid-i-Azam University, Pakistan.






















































































































































Rashna Mirza is a distinguished researcher currently pursuing a PhD at Quaid-i-Azam University, Islamabad, focusing on advanced drug delivery systems, including brain-targeted transfersomes and optimized nano-transfersomes. A Gold Medalist in Pharm D from People’s University of Medical and Health Sciences for Women, she has demonstrated exceptional academic and research prowess. Her professional experience includes roles in quality assurance, pharmaceutical research, and laboratory supervision, showcasing her expertise in drug formulation and optimization. Rashna’s commitment to the field is reflected in her impactful publications and active participation in conferences. Her strengths lie in cutting-edge research, scientific communication, and organizational skills, though expanding her research impact and gaining leadership experience could further enhance her profile. Rashna’s background and achievements make her a strong candidate for the Research for Best Researcher Award.




































































































































Profile







Education














































































































Rashna Mirza’s educational background reflects her strong commitment to the field of pharmaceutics. She is currently pursuing a PhD at Quaid-i-Azam University, Islamabad, with research focused on advanced drug delivery systems, including brain targeting of Cefepime-loaded transfersomes and optimization of nano-transfersomes for transdermal delivery. Prior to her PhD, Rashna completed her M.Phil at the same institution, where she continued to build on her expertise in pharmaceutics. She earned her Pharm D from People’s University of Medical and Health Sciences for Women, where she graduated as a Gold Medalist, underscoring her exceptional academic performance. Rashna’s foundational education includes an FSC Pre-Medical from Government Girls Degree College, Islamabad, and matriculation from Foundation Public School, Karachi. This robust educational background has equipped her with a deep understanding of pharmaceutical sciences and a solid foundation for her research career.
































































































































Professional Experience
































































































































































Rashna Mirza has a diverse professional background that underscores her expertise in pharmaceutics and drug development. Currently pursuing her PhD at Quaid-i-Azam University, she is engaged in pioneering research on brain-targeted drug delivery systems and transdermal gels. Her experience includes working as a Lab Demonstrator at Quaid-i-Azam University, where she managed laboratory work, supervised experiments, and facilitated instructional activities. She also served as a Quality Assurance Inspector at Herbiotics, where she conducted inspections, quality audits, and process monitoring. Additionally, Rashna worked as a Retail Pharmacist at Punjab Pharmacy, handling inventory management, patient counseling, and medication therapy management. Her academic journey is marked by her gold medal achievement in Pharm D from People’s University of Medical and Health Sciences for Women. Her professional roles reflect her strong organizational, supervisory, and research skills, contributing significantly to her field.


























Research Interest




































































































































































































Rashna Mirza’s research interests center on the development and optimization of novel drug delivery systems to enhance therapeutic outcomes. Her current PhD research focuses on innovative approaches such as brain-targeting of Cefepime-loaded transfersomes and the formulation of nano-transfersomes-based chitosan gels for transdermal delivery. This work aims to improve drug efficacy and patient compliance through advanced delivery mechanisms. Rashna is also interested in the formulation and optimization of thermosensitive in situ gels, exploring their potential for controlled and targeted drug release. Her research integrates both in vitro and in vivo studies to address challenges in pharmaceutical science, emphasizing the importance of precise drug delivery for effective treatment. Rashna’s work is characterized by a commitment to advancing pharmaceutics through rigorous experimentation and collaboration, contributing valuable insights to the field and aiming to bridge gaps in current drug delivery technologies.












































































Research Skills












































































































































Rashna Mirza exhibits a strong suite of research skills that underscore her capabilities in advancing the field of pharmaceutics. Her expertise in drug formulation and optimization is evident through her current PhD research, which involves innovative drug delivery systems such as brain-targeting transfersomes and nano-transfersomes. Rashna’s proficiency in statistical design and optimization further enhances her ability to develop and refine novel drug delivery methods. Her hands-on laboratory skills are complemented by her experience in quality assurance and process monitoring, ensuring meticulous evaluation and control of research processes. Additionally, Rashna’s solid background in scientific communication and report writing enables her to effectively present and disseminate research findings. Her involvement in interdisciplinary collaboration and active participation in conferences reflects her commitment to integrating diverse perspectives and advancing scientific knowledge. Overall, Rashna’s research skills demonstrate a well-rounded and impactful approach to pharmaceutics and drug development.




































































































Award and Recognition












































































































Rashna Mirza, a distinguished researcher and Gold Medalist in Pharm D, has garnered significant recognition for her contributions to the field of pharmaceutics. Her innovative research on drug delivery systems, including brain-targeting transfersomes and nano-transfersome optimization, has been widely acknowledged within the scientific community. Rashna’s work is prominently featured in impactful publications, reflecting her dedication to advancing drug formulation and optimization. Her role as a Lab Demonstrator and Quality Assurance Inspector highlights her exceptional skills in scientific communication, process improvement, and interdisciplinary collaboration. Additionally, Rashna’s participation in notable conferences and her involvement in quality audits further underscore her commitment to excellence in pharmaceutical research. These achievements collectively affirm her as a leading figure in her field, earning her well-deserved recognition and positioning her as a promising candidate for prestigious awards in pharmaceutics and drug development.




























































































Conclusion












































































Rashna Mirza’s strong background in pharmaceutics, demonstrated research capabilities, and commitment to advancing drug delivery systems position her as a suitable candidate for the Research for Best Researcher Award. Her strengths in innovative research, academic excellence, and effective communication support her candidacy, while opportunities for broader impact and leadership development could further enhance her profile.






























































































Publication Top Notes


    

  • Brain targeting of cefepime loaded transfersomes based thermosensitive in situ gel via intranasal delivery: In vitro and in vivo studies

      

    • Authors: R. Mirza, A.U. Khan, K.U. Shah, F. Alasmari, Z. Hafeez
      • 

    • Year: 2024
      • 

    • Citations: 1
      • 

    

    • 

  • Statistical design and optimization of nano-transfersomes based chitosan gel for transdermal delivery of cefepime

      

    • Authors: R. Mirza, K.U. Shah, A.U. Khan, Z. Hafeez, S.U. Haq
      • 

    • Year: 2024
      • 

    

    • 



 


 



































































	


	

	






	
	

		


Xin Wang	| Pharmaceutical Science | Best Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Assoc Prof Dr. Xin Wang | Pharmaceutical Science | Best Researcher Award


Assoc. Professor and PhD supervisor of Shanghai Jiao Tong University, China.


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Xin Wang is a Tenure-Track Associate Professor at Shanghai Jiao Tong University, specializing in pharmaceutical and biomedical analysis. He earned his Ph.D. in Analytical Chemistry from Peking University and completed postdoctoral work at MIT and UC Berkeley. His research focuses on mass spectrometry, metabolomics, and proteomics, with key projects including drug metabolism analysis, human neurogenesis studies, and advanced sample preparation techniques. Wang’s contributions have garnered several awards, such as the Shanghai Pujiang Talent Plan Award and recognition at MIT. His expertise in analytical techniques and innovative methods has significantly impacted both academic research and industry practices.
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Professional Profiles:



Education










Xin Wang completed his B.Sc. in Chemistry at Wuhan University, China, in 2010. He pursued his Ph.D. in Analytical Chemistry at Peking University, graduating in 2015. Following his doctoral studies, Dr. Wang undertook postdoctoral research at the Massachusetts Institute of Technology (MIT) from 2015 to 2018. Since 2020, he has been serving as a Tenure-Track Associate Professor at the School of Pharmaceutical Sciences, Shanghai Jiao Tong University, China.


Professional Experience


















Xin Wang’s professional experience includes a significant role as a Tenure-Track Associate Professor at the School of Pharmaceutical Sciences, Shanghai Jiao Tong University, where he has been since 2020. Before this, he was a Senior Postdoctoral Associate at MIT’s Department of Biological Engineering from 2018 to 2019, and a Postdoctoral Associate in the same department from 2015 to 2018. His earlier academic journey includes a Ph.D. in Analytical Chemistry from Peking University, where he also worked as a Visiting Graduate Student at UC Berkeley.










Research Interest


















Xin Wang’s research interests are at the forefront of pharmaceutical and biomedical analysis, emphasizing the use of advanced analytical techniques. His work primarily focuses on mass spectrometry and its applications in drug metabolism and toxicity testing, aiming to replace traditional trials with in vitro human systems. He is also deeply engaged in metabolomics and proteomics, using these techniques to unravel metabolic features in human neurogenesis and other physiological processes. Wang has developed innovative methods in solid-phase microextraction to enhance the sensitivity and accuracy of analyzing low-molecular-mass compounds. His research integrates these areas to advance understanding in drug testing, biomarker discovery, and the mechanistic insights into human health and disease. This multidisciplinary approach not only pushes the boundaries of analytical chemistry but also contributes to more effective and efficient drug development and disease treatment strategies.










Award and Honors










Xin Wang has received several prestigious awards and honors throughout his career. In 2023, he was recognized as an Outstanding Individual with Exceptional Contributions in Education by the School of Pharmacy at Shanghai Jiao Tong University. He also won the Second Prize in the Young Professor Teaching Skills Competition at Shanghai Jiao Tong University in 2022. Wang’s accolades include the Shanghai Overseas High-Level Talent Program Award and the Shanghai Pujiang Talent Plan Award, both in 2020. In 2016, he earned First Place in the MIT Center for Environmental Health Sciences Session. Additionally, he was awarded the First Prize in the Science and Technology Award from the China Association for Instrumental Analysis in 2015. Earlier achievements include the Aoqing Tang Scholarship (2015), the Brilliance Scholarship (2014), and multiple awards for his graduate research and innovation.


Research Skills










Xin Wang possesses advanced research skills in several key areas of analytical and biomedical science. His expertise includes pharmaceutical and biomedical analysis, utilizing techniques such as mass spectrometry, metabolomics, and proteomics to study complex biological systems. He is proficient in solid-phase microextraction and has developed innovative methods for capturing and quantifying low-molecular-mass compounds. Wang’s work with time-dependent metabolomics and LC-MS-based quantitation reflects his ability to apply cutting-edge analytical techniques to understand human neurogenesis and drug metabolism. His research in automated sample preparation and ambient mass spectrometry demonstrates his skills in developing novel methodologies for high-sensitivity detection and analysis. Wang’s contributions to bioanalytical strategies and experimental design have been recognized and published in top scientific journals, showcasing his ability to push the boundaries of current research methodologies.


Publications


    

  1. “Mass spectrometry‐based metabolomics for the investigation of antibiotic–bacterial interactions”

      

    • Authors: Xin Wang
      • 

    • Year: 2024
      • 

    

    2. 

  2. “A new approach towards highly sensitive detection of endogenous N-acetylaspartic acid, N-acetylglutamic acid, and N-acetylaspartylglutamic acid in brain tissues based on strong anion exchange monolith microextraction coupled with UHPLC-MS/MS”

      

    • Authors: Xin Wang
      • 

    • Year: 2024
      • 

    

    3. 

  3. “Mass spectrometry-based quantitation combined with time-dependent metabolomics to discover metabolic features in human neurogenesis using neural constructs generated from neural progenitor cells”

      

    • Authors: Xin Wang
      • 

    • Year: 2023
      • 

    

    4. 

  4. “Mass spectrometry analysis of S-nitrosylation of proteins and its role in cancer, cardiovascular and neurodegenerative diseases”

      

    • Authors: Xin Wang
      • 

    • Year: 2022
      • 

    

    5. 

  5. “Low Doses of Arsenic in a Mouse Model of Human Exposure and in Neuronal Culture Lead to S-Nitrosylation of Synaptic Proteins and Apoptosis via Nitric Oxide”

      

    • Authors: Xin Wang
      • 

    • Year: 2020
      • 

    

    6. 

  6. “Analysis of an Integrated Human Multiorgan Microphysiological System for Combined Tolcapone Metabolism and Brain Metabolomics”

      

    • Authors: Xin Wang
      • 

    • Year: 2019
      • 

    

    7. 

  7. “Automated Online Solid-Phase Derivatization for Sensitive Quantification of Endogenous S-Nitrosoglutathione and Rapid Capture of Other Low-Molecular-Mass S-Nitrosothiols”

      

    • Authors: Xin Wang
      • 

    • Year: 2018
      • 

    

    8. 

  8. “Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function”

      

    • Authors: Xin Wang
      • 

    • Year: 2018
      • 

    

    9. 

  9. “Fast analysis of glycosides based on HKUST-1-coated monolith solid-phase microextraction and direct analysis in real-time mass spectrometry”

      

    • Authors: Xin Wang
      • 

    • Year: 2017
      • 

    

    10. 

  10. “Polymer‐based monolithic column with incorporated chiral metal–organic framework for enantioseparation of methyl phenyl sulfoxide using nano‐liquid chromatography”

      

    • Authors: Xin Wang
      • 

    • Year: 2016
      • 

    

    11. 







 





































	


	

	






	
	

		


Taigang Liang | Drug Design | Best Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Prof. Taigang Liang | Drug Design | Best Researcher Award


Professor at School of Pharmacy/Shanxi Medical University, China.


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Prof. Tai Gang Liang excels in drug synthesis, focusing on developing novel pharmaceutical compounds. His research spans drug action mechanisms, where he explores how drugs interact with biological systems to produce therapeutic effects. Liang is skilled in computer-aided drug design, using computational tools to optimize drug candidates efficiently. He also integrates Traditional Chinese Medicine (TCM) with modern scientific methods to advance drug development and industrialization. His expertise extends to biological evaluation techniques, sustainable synthesis, and analytical methods, ensuring comprehensive assessments of drug efficacy and safety. Prof. Liang’s innovative approaches contribute significantly to enhancing drug discovery and development processes. 🧪🔬💻


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Professional Profiles:



Education


















Prof. Tai Gang Liang, a distinguished scientist at Shanxi Medical University’s School of Pharmacy, has a robust educational background in pharmaceutical sciences. He earned his Doctor of Philosophy (PhD) in 2011, Master of Science (MS) in 2003, and Bachelor of Science (BS) in 2000, all from Shanxi Medical University. His extensive expertise spans drug synthesis, drug action mechanisms, computer-aided drug design, and the industrialization of traditional Chinese medicine (TCM). Prof. Liang’s research is recognized for its contributions to both the development of novel drug compounds and innovative drug design methodologies. His academic journey reflects a deep commitment to advancing pharmaceutical sciences and addressing global health challenges through cutting-edge research.










Professional Experience


















Prof. Tai Gang Liang is a distinguished scientist at the School of Pharmacy, Shanxi Medical University, with extensive expertise in drug synthesis, drug action mechanisms, and computer-aided drug design. His research also focuses on the industrialization of traditional Chinese medicine (TCM). Over his career, Prof. Liang has received several prestigious awards, including being named a Shanxi Province Outstanding Young Scholar and a member of the Shanxi Province “131 Leading Talent Engineering.” He also earned the Silver Prize at the 12th “Challenge Cup” China College Entrepreneurship Plan Competition. His work has made significant contributions to advancing pharmaceutical sciences and TCM research, reflecting his dedication to innovation and excellence in the field.












 Research Interest




















Prof. Tai Gang Liang’s research interests encompass a broad spectrum within pharmaceutical sciences. His primary focus includes drug synthesis and drug action mechanisms, where he aims to develop novel therapeutic agents and understand their biological effects. He is also deeply involved in computer-aided drug design, utilizing computational tools to optimize drug development processes. Additionally, Prof. Liang investigates the industrialization of traditional Chinese medicine (TCM), striving to integrate traditional practices with modern scientific techniques to enhance the efficacy and application of TCM therapies. His research aims to bridge the gap between traditional and modern medicinal approaches, advancing both fields through innovative solutions and interdisciplinary collaboration.














Award and Honors






















Prof. Tai Gang Liang has received several notable awards and honors in recognition of his contributions to the field of pharmaceutical sciences. He was named a Shanxi Province Outstanding Young Scholar, highlighting his exceptional achievements and potential in his research domain. He is also a member of the Shanxi Province “131 Leading Talent Engineering”, an accolade given to influential professionals in the province. Additionally, Prof. Liang was awarded the Silver Prize at the 12th “Challenge Cup” China College Entrepreneurship Plan Competition, reflecting his innovative approach and entrepreneurial spirit in scientific endeavors. These accolades underscore his dedication and significant impact in drug development and traditional Chinese medicine. 🏆🌟


















 Research Skills


























Prof. Tai Gang Liang excels in drug synthesis, focusing on developing novel pharmaceutical compounds. His research spans drug action mechanisms, where he explores how drugs interact with biological systems to produce therapeutic effects. Liang is skilled in computer-aided drug design, using computational tools to optimize drug candidates efficiently. He also integrates Traditional Chinese Medicine (TCM) with modern scientific methods to advance drug development and industrialization. His expertise extends to biological evaluation techniques, sustainable synthesis, and analytical methods, ensuring comprehensive assessments of drug efficacy and safety. Prof. Liang’s innovative approaches contribute significantly to enhancing drug discovery and development processes. 🧪🔬💻














Publications












    

  1. Green synthesis of selenium nanoparticles with extract of hawthorn fruit induced HepG2 cells apoptosis

      

    • Authors: D Cui, T Liang, L Sun, L Meng, C Yang, L Wang, T Liang, Q Li
      • 

    • Year: 2018
      • 

    • Citations: 112
      • 

    

    2. 

  2. Comparison of the Phenolic Content and Antioxidant Activities of Apocynum venetum L. (Luo-Bu-Ma) and Two of Its Alternative Species

      

    • Authors: T Liang, W Yue, Q Li
      • 

    • Year: 2010
      • 

    • Citations: 107
      • 

    

    3. 

  3. Selenium nanoparticles fabricated in laminarin polysaccharides solutions exert their cytotoxicities in HepG2 cells by inhibiting autophagy and promoting apoptosis

      

    • Authors: D Cui, J Ma, T Liang, L Sun, L Meng, T Liang, Q Li
      • 

    • Year: 2019
      • 

    • Citations: 93
      • 

    

    4. 

  4. Synthesis, characterization and antitumor properties of selenium nanoparticles coupling with ferulic acid

      

    • Authors: D Cui, C Yan, J Miao, X Zhang, J Chen, L Sun, L Meng, T Liang, Q Li
      • 

    • Year: 2018
      • 

    • Citations: 78
      • 

    

    5. 

  5. Chemopreventive Effects of Peucedanum praeruptorum DUNN and Its Major Constituents on SGC7901 Gastric Cancer Cells

      

    • Authors: T Liang, W Yue, Q Li
      • 

    • Year: 2010
      • 

    • Citations: 51
      • 

    

    6. 

  6. Farrerol Directly Targets GSK‐3β to Activate Nrf2‐ARE Pathway and Protect EA.hy926 Cells against Oxidative Stress‐Induced Injuries

      

    • Authors: C Yan, X Zhang, J Miao, H Yuan, E Liu, T Liang, Q Li
      • 

    • Year: 2020
      • 

    • Citations: 37
      • 

    

    7. 

  7. Apoptosis induced by farrerol in human gastric cancer SGC-7901 cells through the mitochondrial-mediated pathway

      

    • Authors: E Liu, T Liang, X Wang, S Ban, L Han, Q Li
      • 

    • Year: 2015
      • 

    • Citations: 35
      • 

    

    8. 

  8. Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies

      

    • Authors: C Yan, J Zhang, T Liang, Q Li
      • 

    • Year: 2015
      • 

    • Citations: 35
      • 

    

    9. 

  9. Relaxation of rat aorta by farrerol correlates with potency to reduce intracellular calcium of VSMCs

      

    • Authors: X Qin, X Hou, M Zhang, T Liang, J Zhi, L Han, Q Li
      • 

    • Year: 2014
      • 

    • Citations: 31
      • 

    

    10. 

  10. Sustained ERK activation-mediated proliferation inhibition of farrerol on human gastric carcinoma cell line by G0/G1-phase cell-cycle arrest

      

    • Authors: E Liu, J Li, S Shi, X Wang, T Liang, B Wu, Q Li
      • 

    • Year: 2016
      • 

    • Citations: 26
      • 

    

    11.